Skip to main content

Discovery that Connects

From fundamental insights to better plants, sustainably grown, serving the world

Van Wijk program funded to study chloroplast proteases, furthering potential as molecular factories

3-D models of the Clp protease system in Arabidopsis plastids (From Peltier et al 2004, JBC)

-Magdalen Lindeberg

Chloroplasts not only capture light energy from the sun, but they also have enormous potential as factories for production of transgenic proteins.  Plants generally are a promising source of pharmaceutical and nutritional compounds given their relatively economical production.  One of the best known examples of plant-produced pharmaceuticals is the anti-Ebola drug Zmapp, produced by genetically modified tobacco.

Chloroplasts have particular advantages for protein production. Evolutionarily derived from free-living single celled organisms, chloroplasts have their own genome. Proteins transgenically expressed from the chloroplast genome can accumulate to very high levels and are compartmentalized within the plastid. However, in some cases accumulation is limited owing to protein degradation by chloroplast proteases.

The research program of Klaas van Wijk, SIPS Section of Plant Biology, has received funding from the National Science Foundation to characterize the network of protein degrading enzymes (proteases) at work in the chloroplast. Understanding the dynamics of protein degradation will provide clues on how to design proteins that can accumulate to higher levels. Additionally, describing this process in Arabidopsis thaliana, a plant commonly used in the lab, will provide a model for understanding protein degradation in plant species better suited for large scale production.

This research will build upon past characterization of the Clp protease system by the van Wijk lab.

Read more:


Subscribe By Email

Get every new post delivered right to your inbox.

This form is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Skip to toolbar